Global Annuloplasty System Market Projected to Expand at 6.9% CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Annuloplasty System Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The overall valuation of the annuloplasty system sector has demonstrated considerable expansion throughout the preceding years. Projections indicate a rise from its 2024 valuation of $0.65 billion to $0.7 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.5% over this span. This upward trajectory during the historical timeframe is primarily linked to several concurrent factors: an expanding elderly demographic, the increasing incidence of disorders affecting heart valves, the wider acceptance of surgical procedures requiring minimal invasion, escalating spending within the healthcare domain, and the development and proliferation of specialized cardiology units.

The annuloplasty system sector anticipates robust expansion over the forthcoming years, projected to reach a valuation of $0.91 billion by 2029, driven by a compound annual growth rate (CAGR) of 6.9%. This upward trajectory during the projection timeframe is underpinned by several factors, namely the elevated uptake of less invasive surgical techniques, an increase in transcatheter annuloplasty operations, a growing worldwide incidence of heart conditions, the surging requirement for tailored medical treatments, and ongoing advancements in the field of biomaterials. Key currents shaping this market going forward encompass the incorporation of artificial intelligence into surgical preparation, the innovation of annuloplasty rings capable of being absorbed by the body, a rise in heart valve repair completed through robotic assistance, the greater application of three-dimensional printing technology for creating bespoke implants, and a heightened emphasis on conducting cardiac procedures in outpatient settings.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24143&type=smp

What Are The Top Growth Drivers Impacting The Annuloplasty System Market Outlook?

The rising incidence of ailments affecting the heart and circulatory system is anticipated to fuel the expansion of the market for annuloplasty systems moving ahead. These cardiovascular conditions, a group encompassing issues like coronary artery sickness, cardiac insufficiency, apoplexy, and elevated blood pressure, are becoming more widespread, largely because of an aging demographic where the natural deterioration of cardiac structures with advancing years elevates heart-related risks. Annuloplasty devices contribute significantly to managing these problems by furnishing successful methods for heart valve mending, thus reestablishing appropriate valve performance and optimizing circulation. Their capacity to deliver less invasive pathways for valve restoration means improved results for patients, characterized by shorter recuperation periods and lessened surgical hazards. To illustrate this trend, data released in December 2023 by the Australian Institute of Health and Welfare, a government body in Australia, indicated a rise in physician-confirmed fatalities from coronary heart disease (CHD) within Australia, escalating from 14,100 instances in 2021 to 14,900 recorded in 2022. Consequently, this growing burden of cardiovascular illness directly underpins the forward trajectory of the annuloplasty system market.

What Are The Major Segment Types Covered In The Annuloplasty System Market?

The annuloplasty systemmarket covered in this report is segmented –

1) By Device Type: Annular Rings And Bands, Suture Annuloplasty Devices

2) By Procedure Type: Open Heart Surgery, Minimally Invasive Annuloplasty, Robotic Assisted Annuloplasty

3) By Valve Type: Mitral Valve, Tricuspid Valves, Aortic Valves, Pulmonary Valves

4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers

Subsegments:

1) By Annular Rings And Bands: Rigid Annuloplasty Rings, Semi-Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Complete Annuloplasty Rings, Incomplete Annuloplasty Rings

2) By Suture Annuloplasty Devices: Adjustable Suture Annuloplasty Devices, Non-Adjustable Suture Annuloplasty Devices, Transcatheter Suture Annuloplasty Systems, Robotic-Assisted Suture Annuloplasty Devices

How Are Trends Influencing The Annuloplasty System Market?

Leading firms within the annuloplasty system sector are concentrating their efforts on creating novel offerings, specifically advanced surgical valves and instruments, with the goal of boosting how efficiently procedures are conducted and improving patient results over extended periods. These cutting-edge surgical valves and related apparatus represent sophisticated, recently developed medical tools intended to streamline the installation process, cut down on the intricacy of surgical intervention, and elevate both the accuracy and lifespan of heart valve corrections or substitutes. As an illustration, during June of 2024, Medtronic plc, a medical technology corporation situated in the United States, introduced the Avalus Ultra valve, which is classified as a subsequent generation surgical aortic tissue valve. This state-of-the-art apparatus facilitates easier placement due to its low-profile holder and a lasting frame constructed from polyetheretherketone (PEEK), consequently making surgery simpler and ensuring better performance as time goes on. Furthermore, it promotes superior blood flow characteristics and offers clear visualization capabilities necessary for potential future valve-in-valve interventions.

Which Leading Companies Dominate The Annuloplasty System Market Share?

Major companies operating in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Mesungen AG, Terumo Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, B.Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., Labcor Laboratories Ltd., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A, Cardiac Implants LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/annuloplasty-system-global-market-report

Which Regional Markets Are Contributing Most To The Annuloplasty System Industry Expansion?

North America was the largest region in the annuloplasty system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the annuloplasty system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Annuloplasty System Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24143&type=smp

Browse Through More Reports Similar to the Global Annuloplasty System Market 2025, By The Business Research Company

Implantable Heart Pacemaker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

Heart Pump Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Wearable Heart Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795